Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × NIH × Lymphoid × Clear all

Phase

Phase 2 247 Phase 1 233 Phase 1/2 53 Phase 3 52 Phase NA 22 Phase 2/3 5 Phase EARLY_PHASE1 3 Phase 4 1

Status

Sponsor Class

OTHER 125 INDUSTRY 45 OTHER_GOV 8 NETWORK 4 UNKNOWN 1 NIH 1 INDIV 1 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 2 Gastrointestinal 2 Classical hematology 2 Breast 2 Tumor-Agnostic 1 Sarcoma 1 Lymphoid 1 Head & Neck 1 Endocrine 1 Dermatologic 1 CNS 1

Conditions

Interventions

fluarix 1 arexvy 1 abrysvo 1 Influenza Vaccines 1 Heplisav-B 1 FluLaval 1 BNT162 Vaccine 1 Afluria 1 23-valent pneumococcal capsular polysaccharide vaccine 1 13-valent pneumococcal vaccine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05170399 2026-02-05

Vaccine Responses in Patients With B Cell Malignancies

National Institutes of Health Clinical Center (CC)

Phase 4 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡